BlueRock Therapeutics Empresa Reclamada
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leer más
It has been a great experience so far, exciting!
¿Qué son algunas de las mejores cosas de tu equipo?
It is transparent and we all work well together.
Revisión
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
It is exciting and amazing therapeutics in the pipeline.
Revisión
¿Qué es lo que te hace más feliz en el trabajo?
Being part of something new an exciting in the therapeutic area for patients.
Revisión
¿Qué es lo que más te gusta de tu equipo directivo?
They are clear in their vision and focused on gathering the right talent to move the organization from research to a pre-commercial.
Revisión
Other Employee Reviews for BlueRock Therapeutics
×